Cohort study

Smoking trajectories and residual cardiovascular risk in patients with stable coronary artery disease: an international cohort study

Eur J Prev CardiolPublished

  • Prospective cohort study
  • international registry

Authors' conclusion

Smoking reduction was not associated with improved CV outcomes. Most former smokers quit within a year of CAD diagnosis, and CV risk increase with each subsequent year of active smoking.

Study context

Population
Outpatients with stable coronary artery disease (CAD) (CLARIFY registry)
Participants
32,378 outpatients
Exposure
Smoking cessation vs Never smokers
Outcome
Composite of:
  • CV death
  • MI
Follow-up
5-year follow-up

Main finding

CV death and MI

Adjusted hazard ratio

0.56

95% CI 0.42–0.76

P < 0.001

Smoking cessation vs Never smokers
aHR 0.56 (95% CI 0.42–0.76); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeSmoking cessationSmoking quantity reductionFormer smokersNever smokers
Smoking status at inclusionNot reported in the abstractNot reported in the abstract46.2%Not reported in the abstract
Former smokers who quit within a year of CAD diagnosis
55.7%
  • Smoking status at inclusion: Current smokers 12.5%

Original publication

Smoking trajectories and residual cardiovascular risk in patients with stable coronary artery disease: an international cohort study. Eur J Prev Cardiol. Published 19 April 2025. doi:10.1093/eurjpc/zwaf222

Summarised from the published abstract; every number is checked against it